Statements (36)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:age |
children
infants |
| gptkbp:approvedBy |
gptkb:European_Medicines_Agency
2009 |
| gptkbp:ATCCode |
gptkb:J07AL52
|
| gptkbp:containsAdjuvant |
aluminum phosphate
|
| gptkbp:containsCarrierProtein |
diphtheria toxoid
tetanus toxoid protein D from Haemophilus influenzae |
| gptkbp:containsSerotype |
gptkb:18C
gptkb:19F gptkb:23F 1 14 4 5 6B 9V 7F |
| https://www.w3.org/2000/01/rdf-schema#label |
Synflorix
|
| gptkbp:indication |
pneumococcal disease
|
| gptkbp:manufacturer |
GlaxoSmithKline
|
| gptkbp:marketedIn |
gptkb:Africa
gptkb:Asia gptkb:Europe gptkb:Latin_America |
| gptkbp:numberOfDoses |
3 or 4 (depending on schedule)
|
| gptkbp:routeOfAdministration |
intramuscular
|
| gptkbp:storage |
2-8°C
|
| gptkbp:type |
vaccine
|
| gptkbp:usedFor |
prevention of invasive pneumococcal disease
prevention of acute otitis media |
| gptkbp:WHOPrequalified |
yes
|
| gptkbp:bfsParent |
gptkb:PCV10
|
| gptkbp:bfsLayer |
5
|